D

Dezima Pharma B.V.

10001 employees

Dezima Pharma develops protein-based compounds for treatment of cardiovascular disease related to dyslipidemia.

Basic info

Industry

medical device

Sectors

Biotechnology
Therapeutics

Date founded

2012

Funding rounds raised

Total raised

$19M

from 3 investors over 3 rounds

D

Dezima Pharma B.V. raised $19M on February 28, 2013

Investors: -, BGV (BioGeneration Ventures) and Forbion

FAQ